ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 656209 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 656209; 2) Community: the network communities that were significantly associated with the response to NSC 656209; 3) Molecule: the relationships between components within communities and NSC 656209; 4) MDR: the compounds that were significantly associated with the NSC 656209.

NSC Compound Enrichment Correlation
NSC 294734 7-Oxabicyclo[4.1.0]hept-3-ene-2,5-dione, 3-hydroxy-4-methyl-, (1R-cis)- 0.0312262198176283 0.73295105
NSC 357288 LIATRIS LAEVIGATA LACTONE #2 0.0312262198176283 0.69802036
NSC 603553 2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(4-methoxy phenyl)-, hydrochloride 0.0312262198176283 0.78880994
NSC 623599 4-Methyl-1,2,4-benzotriazin-3(4H)-imine 1-oxide, hydrochloride 0.0312262198176283 0.41247002
NSC 626163 Discorhabdin C-nitrodienone . TFA 0.0312262198176283 0.5191819
NSC 634471 Null 0.0312262198176283 0.43386958
NSC 641536 Quinoline-3-carboxylic acid, 6-chloro-4-phenyl- 2-[(piperazin-1-yl)methyl]-, ethyl ester 0.0312262198176283 0.39100916
NSC 659390 Null 0.0352383000003052 0.67606913
NSC 661581 2-Azabicyclo[16.3.1]docosane, geldanamycin deriv. 0.0352383000003052 0.69387541
NSC 665622 Cyclohexanone, 2,6-bis[(1-pyrrolidinyl)methyl]-, dihydrochloride 0.0352383000003052 0.75046119
Total:76  Current:59    [First] [Prev] [Next] [Last]